Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/8/26 16:18 | 4/7/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 3 | M.d | 1,079 | 51.29 | 0 | 21 | 16 | 154 | D | ||||||||||||||
4/8/26 16:18 | 4/7/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 3 | S.d | -1,079 | 51.29 | 0 | -21 | 154 | D | |||||||||||||||
4/1/26 16:34 | 4/1/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 2 | S | -2,774 | 62.91 | 0 | -44 | 434 | D | |||||||||||||||
3/31/26 16:21 | 3/31/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 13 | S.d | -4,991 | 48.01 | 0 | -104 | 78 | D | |||||||||||||||
3/18/26 17:46 | 3/17/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Lee Sung | CA | O | EVP,CFO | 1 | S | -307 | 62.15 | 0 | -5 | 87 | D | |||||||||||||||
3/2/26 16:29 | 3/2/26 | CYTK | Health | Drug | Pharmaceutical Preparations | Parshall B Lynne | CA | D | 1 | S | -306 | 61.21 | 0 | -5 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |